🇺🇸 FDA
Pipeline program

AU-011

AU-011-202

Phase 2 small_molecule completed

Quick answer

AU-011 for Uveal Melanoma is a Phase 2 program (small_molecule) at Aura Biosciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Aura Biosciences
Indication
Uveal Melanoma
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials